AFT - Retirement of Anita Baldauf

Monday 1st July 2024

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Anita Baldauf has announced her intention not to seek re-election and to retire as a director of the company at the upcoming shareholders meeting on Friday 2nd August 2024.

Chair David Flacks said: “On behalf of the Board, I would like to sincerely thank Anita for her valuable contribution and service during her four-year tenure. Her industry knowledge and international finance and marketing experience has been of great assistance to AFT particularly in its continued growth internationally.”

The Board will now commence a recruitment process for a replacement director, and further details will be announced in due course.

Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief Financial Officer.

For more information:

Investors Media

Dr Hartley Atkinson Richard Inder

Managing Director The Project

AFT Pharmaceuticals Tel: +64 21 645 643

Tel: +64 9488 0232

About AFT Pharmaceuticals (ASX:AFP, NZX: AFT )

www.aftpharm.com

AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over the counter, prescription, and hospital. AFT Pharmaceutical's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs.

Retirement of Anita Baldauf

Comments from our readers

No comments yet